Distinguished ProfessorXu-Feng Huang
Distinguished Professor
School of Medical, Indigenous and Health Sciences
- Distinguished ProfessorSchool of Medical, Indigenous and Health Sciences
- University of Wollongong, 32.305 IHMRI, Northfield Avenue, Keiraville, NSW, 2522, Australia
BIO
Xufeng Huang is a Distinguished Professor and Deputy Head of School (Growth and Global) at the University of Wollongong, NHMRC Senior Research Leadership Fellow, Fellow of the Royal Society of New South Wales and President of e-ASIA Society for Metabolic Syndrome Through Nutrients and Lifestyle.
Metabolic neuroscientist Professor Xufeng Huang defined how brain–metabolic control progressively fails during diet-induced obesity. His three-stage model transformed central leptin resistance from a feature of established obesity into a staged pathological process with region-specific and reversible components, revealing the sequence and sites of failure and an earlier intervention window. He extended this framework to obesity-related neurodegeneration, cognitive decline and antipsychotic-induced metabolic harm. These discoveries generated nutritional and neuroprotective interventions, metabolically safer antipsychotic candidates advanced through international patent filing, industry-supported development and policy evidence, and now underpin an NHMRC-supported, Australia-led four-country clinical program developing personalised dietary interventions for metabolic-syndrome control.
His research impact is reflected in 322 peer-reviewed papers and 8 books, with 23,326 citations and an H-index of 84. It has influenced 47 international policy documents, generating 63 primary citations and 175 downstream citations across 139 policy papers (SagePolicyProfiles, 2025), demonstrating sustained impact on public health policy and guidelines.
Beyond research, his impact extends to education and capacity building, with over 3 decades of teaching, development of core curricula, and training of more than 100 researchers, many of whom now hold academic leadership positions internationally.
As Chief Investigator A (CIA), he has led 9 NHMRC grants over 27 years and 8 industry-funded grants, including collaborations with AstraZeneca, Uncle Toby’s, Clover Corporation, and the Schizophrenia Research Program (NSW Health), advancing the translation of neuro-metabolic research into practical health solutions. He has secured a total of $26.98 million in research funding.
Currently, as Chief Investigator A of the NHMRC e-ASIA Joint Research Program, he leads the development of a systems-level biotechnological framework integrating biomarker-guided approaches, digital nutrient delivery, and coordinated clinical trial infrastructure across four nations (Australia, Indonesia, Thailand, and the Philippines), advancing scalable, prevention-focused strategies for metabolic health.
Fellowships
- FRSN Fellow of The Royal Society of New South Wales, Australia, 2024-
- NHMRC Senior Research Leadership Fellow, Australia, 2021
- EEF Endeavour Executive Fellow, Government Department of Education and Training, Australia, 2017
Awards
- Professor Justin Yerbury AM Award for Research and Scholarship-Finalist, University of Wollongong Alumni Awards, 2025
- Vice-Chancellor’s Award for Interdisciplinary Research, University of Wollongong, 2020
- Vice-Chancellor’s Research Excellence Award for Senior Researcher of the Year, University of Wollongong, 2014
- Vice-Chancellor’s Award for Excellence in Research Supervision, University of Wollongong, 2010
- Vice-Chancellor’s Award for Excellence in Research Supervision (Highly Commended), University of Wollongong, 2009
- PhD Scholarship Award, National Health and Medical Research Council, Australia, 1989
UNIVERSITY OF WOLLONGONG APPOINTMENTS
- Distinguished ProfessorFaculty of Science, Medicine and Health, School of Medical, Indigenous and Health Sciences, Wollongong, Australia1 Jan 2018 - present
- NHMRC Principal Research FellowUniversity of Wollongong, School of Medical, Indigenous and Health, Wollongong, Australia1 Aug 2019 - 1 Aug 2025
- Senior ProfessorUniversity of Wollongong, School of Medical, Indigenous, and Health Sciences, Wollongong, Australia1 Jan 2014 - 1 Jan 2017
- ProfessorUniversity of Wollongong, Department of Biomedical Science, Wollongong, Australia1 Jan 2006 - 1 Jan 2014
- Senior LectureUniversity of Wollongong, Department of Biomedical Science, Wollongong, Australia1 Jan 1997 - 31 Dec 2005
MEDIA
ACADEMIC POSITIONS
- Theme Leader of the Mental Health and Ageing Brain (Clinic) Illawarra Health and Medical Research InstituteThe University of Wollongong, School of Medicine, Wollongong, Australia1 Jan 2017 - 1 Jan 2019
- Director of Centre for Translational NeuroscienceUniversity of Wollongong, School of Medicine, Wollongong, Australia1 Aug 1995 - 1 Aug 2019
- Deputy Executive Director (Scientific) Illawarra Health and Medical Research InstituteUniversity of Wollongong, Wollongong, Australia1 Jan 2011 - 1 Jan 2016
- Executive Director (Acting) Illawarra Health and Medical Research InstituteUniversity of Wollongong, Wollongong, Australia1 Jan 2012 - 1 Jan 2013
DEGREES
- PhDUniversity of New South Wales, School of Medicine, High Street, Sydney, NSW, 2033, Australia1989 - 1993
- DScUniversity of Wollongong, School of Biomedical Sciences, Northfield Avenue, Wollongong, NSW, 2500, Australia2009 - 2012
- MDXuzhou Medical University, School of Medicine, 209 Tongshan Road, Xuzhou, Jiangsu, 221004, China1977 - 1985
POSTGRADUATE TRAINING
- Post-doctoral fellowUniversity of New South Wales, Psychology, Sydney, AustraliaBrain SciencePostdoctoral FellowshipSupervised by Professor George Paxinos G
- Post-doctoral fellowThe University of New South Wales, Australia, Pathology, Sydney, AustraliaNeuropathologyPostdoctoral FellowshipSupervised by Prof Stanley Catts S
LANGUAGES
- EnglishCan read, write, speak, understand and peer review
- Chinese (Mandarin)
AVAILABILITY
- Masters Research or PhD student supervision
SDGS
- 3 Good Health and Well Being
- 4 Quality Education